Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary
glands, representing approximately 1% of all head and neck carcinomas and 10% of all …

Background Updated epidemiologic and survival data of head and neck adenoid cystic
carcinoma (HNACC) are lacking. This retrospective study aimed to clarify the incidence …

Objective To compare treatment outcomes for T4b head and neck adenoid cystic carcinoma
(ACC). Study Design Historical cohort study. Setting National Cancer Database (NCDB) …

Introduction Adenoid cystic carcinoma of minor salivary glands (AdCCmSG) represents a
'rarity in the rarity,'posing a clinical challenge in lack of standardized, evidence-based …

Simple Summary Adenoid cystic carcinoma (ACC) is known to have distinctive clinical
features. It tends to metastasize to the lungs and spread through the nerves. As the nasal …

Purpose: Head and neck adenoid cystic carcinoma (HNACC) is a radioresistant tumor.
Particle therapy, primarily proton beam therapy and carbon-ion radiation, is a potential …

Purpose Adenoid cystic carcinoma (ACC) is a rare malignancy accounting for 1% of all head
and neck cancers. Treatment for ACC has its challenges and risks, yet few outcomes studies …

Purpose: An indolent nature, with a high risk of local recurrence along with the potential for
distant metastases, makes the relatively rare adenoid cystic carcinomas (ACCs) of the head …

Background Treating patients with head and neck adenoid cystic carcinoma (HNACC)
presents surgical problems in various scenarios. Limited studies explore definitive …